Novartis hands investors Alcon spin-off and $5 billion share buyback
June 29, 2018 at 04:14 AM EDT
ZURICH (Reuters) - Novartis plans to spin off its Alcon eye care business to shareholders and repurchase up to $5 billion in shares, as Chief Executive Vas Narasimhan refocuses the Swiss firm on prescription drugs.
